No Institutional Review Board (IRB) has provided ethical and regulatory oversight for more trials or investigators than the WIRB-Copernicus Group® (WCG).

We review over 3,000 new protocols and 15,000 investigators annually; that’s over 200,000 protocols to date, spanning nearly every conceivable therapeutic area. As a result, only WCG possesses the breadth and depth of expertise to support a wide spectrum of research review.

Our advisors and review board members include the leading experts in every major clinical specialty, enabling us to provide highly specialized review services in the therapeutic areas to which most research funding is directed.

Print Friendly, PDF & Email